swissnex Brazil presents the webinar HealthTech Opportunities in Brazil for Swiss healthcare startups, especially those focused on diagnostics technologies and interested in learning how to start an innovative business in Brazil. To help entrepreneurs to overcome the initial lack of information about the Brazilian ecosystem, an open innovation specialist at one of Brazil’s major private healthcare providers and a regulatory expert will address market opportunities, the macroeconomic scenario, and answer questions.
The webinar will also introduce Innosuisse’s Market Entry Camps and detail the tools offered by the Swiss government to support the internationalization process for startups interested in exploring the Brazilian market.
|10:05||Diagnostics Market in Brazil and Latin America, success case with international startup, DASA’s Open Innovation Program – Claire Bottero|
|10:20||Regulatory process in Brazil, main challenges/barriers, main advantages for international companies when entering the Brazilian market, Success case – Marco Aurelio Torrenteguy|
|10:35||Innosuisse Market Entry Camp Opportunities – Amanda Akemi (swissnex Brazil’s Startup & Innovation Program Manager)|
Pharmaceutical with post-graduation in investments and strategy from ESSEC Business School, Claire is responsible for the Scouting and Strategy part for clinical and genomic analysis at Dasa. She is also the focal point of Cubo Health, Latin America’s biggest innovation hub.
Partner in TozziniFreire’s Life Sciences and Healthcare practice group, Marco Aurélio has broad experience in regulatory matters and administrative health regulatory proceedings. He assists clients in several sectors of the industry on consulting and administrative procedures, especially before ANVISA (Brazilian Health Regulatory Agency) and MAPA (Brazilian Ministry of Agriculture, Livestock, and Food Supply). He acts in matters related to the licensing and registration of products subject to health surveillance, new technologies, the launch of new products in the Brazilian market, and drug recall.